Israel-based Scopio Labs announced the FDA granted De Novo clearance for its Full-Field Bone Marrow Aspirate (FF-BMA) software that provides AI-enabled decision support tools for bone marrow analysis.
The FF-BMA application allows for bone marrow aspirate analysis. It combines full-field imaging and an AI-powered decision support system that allows hematopathologists to analyze bone marrow...
